Response to: ‘Comment on Transitioning to intravitreal aflibercept following a previous treat-and-extend dosing regimen in neovascular age-related macular degeneration: 24-month results’
作者
Natalie Homer,Dilraj S. Grewal,Rukhsana G. Mirza,Alice T. Lyon,Manjot K. Gill